Pacing |
ADAPTA™ with MVP™
Pacing System
Intrinsic and Automatic
Pacing Redefined, The New Standard
The new standard of care in pacing is to reduce unnecessary right ventricular pacing to as close to zero as possible. Mounting evidence suggests that right ventricular pacing is associated with a variety of detrimental effects, including risk of heart failure hospitalization and atrial fibrillation.1
The Adapta pacing system combines physiologic pacing with automaticity.
MVP™—Managed Ventricular Pacing
Intrinsic conduction when you have it, the safety of pacing when you need it.
- Promotes intrinsic conduction
- Reduces unnecessary right ventricular pacing by 99%*2
- Provides AAI(R) pacing with ventricular monitoring plus the safety of DDD(R) backup pacing when needed
Completely Automatic—Simple to Use
Atrial Capture Management and Ventricular Capture Management (ACM and VCM)
- Provide complete long-term threshold management automatically
- Ensure pacing outputs remain at safe levels3
- Adapt programmed outputs to maximize longevity
- Simplifies and tailors programming
- Provides recommended device settings based on physician-selected patient conditions
- Simplifies clinic follow-up with all key information on one screen
- Provides concise overview of patient, device, and lead status
Concise information to:
- Identify atrial arrhythmias
- Make key therapy decisions (e.g., titrating medications)
- Monitor results of therapy changes
Pacing therapies that may help manage tachyarrhythmias and may alleviate symptoms:
- Atrial Preference Pacing (APP)
- Post Mode Switch Overdrive Pacing (PMOP)
- Conducted AF Response
Medtronic CareLink® Network for Pacemakers
Now available! Medtronic CareLink® Network, the leading Internet-based remote monitoring service, is available for pacemakers.
*Median number
References
- Sweeney M, Hellkamp A, Ellenbogen K, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107:2932-2937.
- Gillis A, Pürerfellner H, Israel C, et al. Reduction of unnecessary ventricular pacing due to the Managed Ventricular Pacing (MVP) mode in pacemaker patients: Benefit for both sinus node disease(SND) and AV block (AVB) indications. Heart Rhythm . 2005;Abstract AB21-1.
- Ref Heart Rhythm, Vol. 2, No 11, November 2005
Additional Information
|
©Medtronic, Inc. 2008 • Contact Medtronic • Privacy Statement • Terms of Use • Site Map